NUTRIBAND INC

NTRBNASDAQ

🏆 #3804 by market capEarnings Sep 30US Equity

$3.18▲ $0.04 (+1.27%)

🌅 Pre-market$3.18▲ 0.00%Regular close · extended-hours price shown

1h—

24h▲ 1.3%

7d▲ 12.0%

14d▲ 8.5%

30d▲ 7.3%

1y▼ 52.8%

🏦Market Cap

$39M

Small Cap

📈Revenue Growth (YoY)

-24.8%

Declining

📊Gross Margin

28.4%

Moderate

💵FCF Margin

—

⚖️P/S Ratio

21.2x

Expensive

Otter Score

Weak

Trading Snapshot

Day Range: $3.15 – $3.24
52-Week Range: $2.80 – $8.63
Volume: $2.22B
Avg Volume: $2.53B
Shares Outstanding: 12.2M
Next Earnings: Oct 9, 2026

Fundamentals Snapshot

Annual Revenue: $2M
Last Q Revenue: $433,399
P/E Ratio: —
P/S Ratio: 21.2x
EPS (TTM): $-0.68
Dividend Yield: —

Why Investors Own NTRB

✓High-growth profile — revenue up +55.9% YoY with expanding US Equity exposure.
✓Healthy economics — 68% gross margin and 15% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$2M▲ +57.1% YoY

Gross Margin (TTM)

68.3%▲ +0.7% YoY

Operating Income (TTM)

$224,032▲ +57.1% YoY

Free Cash Flow (TTM)

$305,498▲ +57.1% YoY

About NUTRIBAND INC

Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.

🦦